Advertisement

Topics

Latest "BioTech Capital Limited" News Stories

10:44 EDT 23rd May 2018 | BioPortfolio

Here are the most relevant search results for "BioTech Capital Limited" found in our extensive news archives from over 250 global news sources.

More Information about BioTech Capital Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioTech Capital Limited for you to read. Along with our medical data and news we also list BioTech Capital Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioTech Capital Limited Companies for you to search.

Showing "BioTech Capital Limited" News Articles 1–25 of 10,000+

Wednesday 23rd May 2018

BioGENEius Challenge 2018 BioSTEM Leader Awardee

Today, the Biotechnology Institute announced the winner of the BioSTEM Leader Award, who will be recognized next week at the 2018 Biotechnology Industry Organization Annual Convention (BIO 2018) in Boston. We would not have the quality of national excellence at the BioGENEius Challenge or the talent to feed our future biotechnology workforce were ...


Empower Clinics Adds Brand and Marketing Pioneer Peter McDonough to Board of Directors

Empower Clinics Inc. (CSE: EPW), a leading owner and operator of medical cannabis clinics in the US, today announced that Peter McDonough, one of the world’s leading brand and marketing executives, has joined its Board of Directors, effective immediately. McDonough has more than 30 years leadership experience in building and managing some of th...

The Avoca Group Announces Speaker Lineup for the 7th Annual AQC Global Quality Summit

The Avoca Group has announced the full speaker lineup for the 7th Annual AQC® Global Quality Summit, taking place 13-14 June 2018 in Dublin, Ireland. The theme for this year's event - Embrace the Present. Own the Future. - focuses on today's most innovative solutions for driving efficiency, improving quality, and mitigating risk in the execution of clinic...


Techsol Corporation Unveils the Latest Release of MedInquirer

Techsol Corporation, a leading life sciences cloud technology services provider, announces the latest release of MedInquirer. As the industry’s most configurable medical information management system, MedInquirer is primarily sought by pharma, biotech's, medical device manufacturers and medical information call centers to quickly respond to medical inquiries, manage product complaints and ad...

Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more

News from the frontline of pharma, biotech and healthcare

Astero Bio Acquires Key Technologies for the Management of Cryopreserved Biologics from BroadOak Capital Partners

Astero Bio Corporation, a leader in the development of innovative tools for cryopreserved biologics, and BroadOak Capital Partners, LLC, a privately held investment bank with a comprehensive focus on the life science industry, today announced a partnership in which Astero will acquire the former assets, and all relate

Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors

Press release Malmö, May 23, 2018 Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors Acarix, developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment, today announced the appointment of a highly experienced marketing expert, Johanne Louise Brændgaard, as a member of the board of directors. "We are delighted to w...

Check Out the Agenda for New York Biotech: Bringing Back the Expats

We’ve just posted the agenda for New York Biotech: Bringing Back the Expats, which is set for June 21 at Riverpark at the Alexandria Center in New York. We are bringing together a few biopharma leaders who are ex-New Yorkers to lead a unique, candid discussion with the local biotech community. Why did they leave […]

Patent Application by Biotech Support Group LLC Describes New Cancer Serum Biomarker Panel- Stroma Liquid Biopsy™ That Offers Avenues for Early Cancer Detection

Stroma Liquid Biopsy™ offers methods to monitor and potentially modulate the systemic response to cancer, opens new avenues for early detection, personalized medicine and therapeutic modalities. MONMOUTH JUNCTION, N.J. (PRWEB) May 23, 2018 Biotech Support Group announced today that it has filed a patent application on Stroma Liquid Biopsy™, describing a biomarker panel of cancer dysregulation...

Translate Bio Names John R. Schroer, CFA, Chief Financial Officer

Translate Bio, a leading messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, today announced the appointment of John R. Schroer, CFA, as Chief Financial Officer. With 28 years of healthcare investment experience, Mr. Schroer brings expertise in fin...

PAVmed Updates Expected Key Dates for Previously Announced Rights Offering

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company”), a highly differentiated, multiproduct medical device company, previously announced on May 8, 2018 that the Company had filed a preliminary prospectus as part of a registration statement on Form S-1 with the Securities and Exchange Commission for a rights offering (the “Rights Offering”) to stockhol...

CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”

CAR-T. Gene therapy. RNA interference. These aren’t just science experiments. They’re real, cutting-edge medicines either just on the market or soon to be. And the implications of their arrival was the focus of a few spirited discussions at Xconomy’s “What’s Hot in Boston Biotech” event last week at the Broad Institute in Cambridge, MA. Today, […]

Acarix AB recruits Per Persson as Chief Commercial Officer

Press release Malmö, May 23, 2018 Acarix AB recruits Per Persson as Chief Commercial Officer  Acarix AB (publ) ("Acarix"), today announced the recruitment of Per Persson as new Chief Commercial Officer to accelerate the sales execution for the CADScor®System for Coronary Artery Disease (CAD) risk assessment. He has a solid background in sales and marketing of medical technology ...

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

Strategic Seed Investors Include Kite Pharma Founder, Arie Belldegrun, M.D., FACS, Chairman of Gilead Sciences, John Martin, Ph.D., Norbert Bischofberger, Ph.D., Omega Funds and Vida Ventures Kronos Bio, Inc. (Kronos), a Two River portfolio company, today announced the appointment of Norbert Bischofberger, Ph.D. as its President and Chief Executive Off...

Peptide Display Company Orbit Discovery Closes £6.9M Series A Financing

Oxford, UK, May 23, 2018 / B3C newswire / -- Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further in...

Lava Therapeutics Raises EUR 16 Million to Advance Bispecific Gamma-Delta T Cell Engager Platform

--Biologics Expert Paul Parren Joins as Head of R&D-- Lava Therapeutics (“LAVA”) today announced it has raised EUR 16 million in its first major institutional financing round from an investor syndicate led by Gilde Healthcare and Versant Ventures with additional support from US-based MRL Ventures Fund (MRLV), joining founder investors Lupus Ven...

Opinion: Diversity in the biopharma industry makes dollars and sense

Biotech CEOs who want to continue receiving investments from some of the largest players in the financial services sector should hear and heed their messages about diversity.

A new VC firm will invest in your startup — and pay for you to get therapy and acupuncture

A new San Francisco venture capital firm here is betting that overworked, unhealthy startup founders are bad for the bottom line.

FIT Biotech Oy: FIT Biotech files two international patent applications

FIT Biotech Oy  Company release 23.5.2018 at 9.30 EET FIT Biotech files two international patent applications FIT Biotech Oy ("company", FITBIO:FN Finland) has filed two international patent applications. These applications are of strategic importance as the company continues to work towards the commercialization of its technology and therapeutic candidates. The first...

3 Things In Biotech, May 22: Breast Cancer Disruption!

Tear Film Innovations secures funding for iLux evaporative dry eye system

Tear Film Innovations (TFI) has secured $8.5m funding, which will serve as growth capital for the iLux evaporative dry eye system.

Iora Health Lands $100M for Relationship-Driven Primary Care Model

Iora Health, a Boston, MA-based value-based primary care provider focused on Medicare has raised $100 million in Series E funding from global investors including .406 Ventures, Devonshire Investors, F-Prime Capital, Flare Capital Partners, GE Ventures, Humana, Khosla Ventures, Polaris Partners and Temasek. The company plans to utilize the funding to expand operations and invest further ... Read Mo...

Tuesday 22nd May 2018

OMFIF:La recuperación económica y el rally de la renta variable engrosan los activos del ...

La recuperación económica global y el repunte en los mercados de capital impulsó los activos los bancos centrales, los fondossoberanos y los fondos de pensiones públicas por 2,5 billones de dólares en 2017, según Global Public Investor, publicado anualmente por OMFIF, el think-tank con sede en Londres y Singapur. El incremento de 2,5 billones de...

Victory Capital Management Inc. Boosts Stake in Cardinal Health

Victory Capital Management Inc. lifted its stake in shares of Cardinal Health by 21.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 186,392 shares of the company's stock after buying an additional 32,314 shares during the period.

Global and China Bio Nematicides Market Research by Company, Type Application 20132025 [Report Updated: 07032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Conventional Sulphur Dyes Solubilized Sulphur Dyes Leuco Sulphur DyesBy Application Oilseeds Pulses Fruits Vegetables Cereals Grains OthersBy Company Dow Agro Sciences FMC Corporation BASF SE Bayer Crop Science Monsanto Company Syngenta Certis USA Marrone Bio Innovations Valent Bio Sciences Andermatt Bio...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks